Novo Nordisk Skeptic Finally Upgrades Stock
Bearish flow noted in Novo Nordisk (NVO) with 7,917 puts trading, or 1.2x expected. Most active are 3/14 weekly 76 puts and Sep-25 110 puts, ...
Novo Nordisk (NYSE: NVO) shareholders know all ... Unfortunately, shares of the company behind Ozempic have been trading about 39% below last year's peak. Now that it's been beaten down, ...
Novo Nordisk said on Wednesday it would begin selling ... US-listed shares of Novo were up 4.2% to $91.16 in morning trading. Compounding pharmacies that have been selling hundreds of ...
Competition from Him & Hers Health seems to be weighing on Novo Nordisk's stock. A half-hearted rating from Morgan Stanley yesterday isn't cheering investors up very much at all. Yet a new study ...
Hims stock stood about 22% lower in recent trading. Novo Nordisk shares jumped as much as 4% in Denmark. Hims will stop offering mass compounding of semaglutide after the first quarter ...
Novo Nordisk A/S's CagriSema faces challenges, yet new trials aim to enhance efficacy, rival Eli Lilly in obesity treatments, ...
The stock is currently trading above its 50-day moving average but below its 200-day moving average. Several factors in the past three months caused Novo Nordisk's stock to dip. In December 2024 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results